Early Alzheimer’s Combination Therapy Study
You may have heard about lecanemab (Leqembi) in the news over the past year, that it is one of the latest FDA-approved drugs to help in the fight against Alzheimer’s. Did you know that even though drugs like this are approved for the public, pharmaceutical companies continue to research their benefits? This study looks at […]
Preliminary Qualifications
-
You are 50-80 years of age.
-
You have a diagnosis of mild Alzheimer's disease.